Pregled bibliografske jedinice broj: 655456
Flutamide-induced acute hepatitis in advanced prostate cancer patients
Flutamide-induced acute hepatitis in advanced prostate cancer patients // International journal of clinical pharmacology and therapeutics, 39 (2001), 9; 395-399 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 655456 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Flutamide-induced acute hepatitis in advanced prostate cancer patients
Autori
Kraus, Ivan ; Vitezić, Dinko ; Oguić, Romano
Izvornik
International journal of clinical pharmacology and therapeutics (0946-1965) 39
(2001), 9;
395-399
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
flutamide ; acute hepatitis ; advanced prostate cancer
Sažetak
OBJECTIVE: To describe the characteristics of 3 patients hospitalized in the Department of Gastroenterology, University Hospital Center, Rijeka, as the result of acute hepatitis, a rare adverse drug reaction to flutamide. PATIENTS AND RESULTS: All 3 patients with advanced prostate carcinoma were treated with oral flutamide at a dose rate of 250 mg 3 times daily. The patients developed clinical signs (jaundice, anorexia, nausea, dark urine etc.) and laboratory liver function test changes (high aminotransferase and bilirubin level), indicative of acute hepatitis, 20-22 weeks after commencing flutamide treatment. The flutamide therapy was immediately discontinued and this resulted in spontaneous remission (clinical and liver function test results returned to normal) during the next 8 weeks. CONCLUSION: Our data clearly suggest that flutamide causes acute hepatitis and that the monitoring of the patients' liver function tests in order to detect these changes as early as possible, is important.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE